bullish
Weekly Stock Bullfinder - Week of 7/4
SUMMARY
- With market damage becoming worse by the week, identifying promising setups becoming fewer and fewer as most groups and sectors in bad Stage 4 declines, continually rejecting at key moving averages in each bear market rally in 2022.
- I have no interest in speculative biotech and wouldn’t put a dime in a Chinese stock.
- Playing defense and resisting buying into a Stage 4 decline is key as the macroeconomic data continues to soften and revert back to pre-COVID trends after the “sugar high” of low interest rates and fiscal stimulus wear off.
Get started on the Smartkarma Research Network with a complimentary Preview Pass to:
- Unlock all research summaries
- Follow top, independent analysts
- Receive personalised alerts and emails
- Access Briefings, Analytics, and Events
Upgrade anytime to our paid plans for full-length research, real-time analyst discussions, and more.
Join a thriving community of 45,000+ investors, including the top global asset managers managing over $13trn in assets.
or
Already have an account? Sign In Now
Discussions
(Paid Plans Only)
x